Aspira Womens Health Inc. buy krebskrebs
Start price
24.01.22
/
50%
€14.78
Target price
24.01.23
€24.00
Performance (%)
-57.36%
End price
25.01.23
€6.30
Summary
This prediction ended on 25.01.23 with a price of €6.30. Massive losses of -57.36% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aspira Womens Health Inc. | - | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by krebskrebs for this prediction
In the thread Vermillion Inc. diskutieren
Buy mit Kursziel 1,6
In the thread Trading Vermillion Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

